Evaluation of antipsychotic information on UK schizophrenia websites

G. Akram, A.C. Boyter, A.H. Thomson

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

The aim and methods of this paper are to evaluate the quality of information about medication on 33 UK schizophrenia websites using a bespoke tool known as the Strathclyde Website Evaluation Form (SWEF). The mean total SWEF score was 26 out of a maximum of 52. For website content, the mean score was 15.3 out of a maximum of 32. Most websites mentioned antipsychotics (n = 23), but only 10 described the differences between typical and atypical classes. Three websites mentioned the different injectable formulations. Information about side-effects, particularly from atypicals was limited. Comprehensive details about clozapine including the blood monitoring requirements were found on two websites. Currency was reasonable with 20 websites being less than 3 years old. Information about antipsychotic medication on UK schizophrenia websites is basic and incomplete.
Original languageEnglish
Pages (from-to)422-426
Number of pages5
JournalPsychiatrist
Volume34
Issue number10
DOIs
Publication statusPublished - Oct 2010

Keywords

  • antipsychotics
  • websites
  • pharmacology

Fingerprint

Dive into the research topics of 'Evaluation of antipsychotic information on UK schizophrenia websites'. Together they form a unique fingerprint.

Cite this